Neoplasms Clinical Trial
Official title:
Effectiveness of an Integrated Experiential Training Program With Coaching by Nursing Students in Promoting Regular Physical Activity and Reducing Fatigue Among Childhood Cancer Patients
Background: Despite the evidence that regular physical activity can have beneficial effects
on the physical and psychological well-being of cancer patients, a review of the literature
reveals that a majority of young cancer patients fail to attain the same levels of physical
activity that they had before contracting the disease. There is scientific evidence that
physical inactivity induces muscle catabolism and atrophy and cardiovascular diseases, which
may lead to a further increase in fatigue and a decrease in the functional capacity of cancer
patients. Empirical evidence is needed to explore an appropriate strategy for promoting
physical activity in such patients.
Purposes: To examine the effectiveness of an integrated experiential training program with
coaching by nursing students in promoting regular physical activity, reducing fatigue and
enhancing quality of life among Hong Kong Chinese childhood cancer patients.
Design and Subjects: A randomised controlled trial (RCT), two-group pre-test and repeated
post-test, within and between subjects design will be conducted. Recruitment of subjects will
be carried out in a paediatric oncology ward of a Hong Kong acute care hospital.
Intervention: Participants in the experimental group will join an integrated experiential
training program with coaching by nursing students, which contains 28 home visits by a
designated nursing student as a coach for a 6-month period. Those in the placebo control
group will receive an amount of time and attention (home visits by research assistants) that
mimics that received by the experimental group.
The aim of this study is to examine the effectiveness of an integrated experiential training
program with coaching by nursing students in promoting regular physical activity, reducing
fatigue and enhancing quality of life among Hong Kong Chinese childhood cancer patients.
Intervention
Experimental group
During hospitalization for cancer treatment, besides receiving usual care, a registered nurse
will deliver participants a health education talk. Participants will then be taught and
encouraged to practice some simple stretching and relaxing exercises. After discharged from
the hospital, participants in the experimental group are scheduled to take part in an
integrated experiential training program with coaching by nursing students. Each participant
is allocated to a nursing student who was voluntarily trained as coaches for the program. The
intervention is implemented to each participant by the designated coach during 28 home visits
throughout a 6-month period (24 weeks) and each visit lasts for about 1 hour. The 1-hour
program consists of a 30-minute English tutorial session, and a 30-minute physical activity
session with the coach. The same coach pays a visit to a participant at twice a week for the
first 4 weeks and then once a week for the subsequent 20 weeks. During the individual
coaching sessions with the young people, the coaches will teach and demonstrate physical
activities in 4 levels to the participants according to participants' ability.
Placebo control group
Since participants in both groups are hospitalized in the same unit, to avoid contamination,
participants in the placebo control group will receive the same intervention as those
participants in the experimental group during their hospitalization. When discharged home,
participants will receive an amount of time and attention (home visits by research
assistants) that mimicked that received by the experimental group, but which is thought not
to have any specific effect on the outcome measures. The activities during the home visits
over a six-month period include playing cards or chess games, health advice on the prevention
of influenza and healthy diet which will be conducted for 30 minutes.The participants will
also receive a 30-minute English tutorial session with the research assistants in each home
visit.
To ensure the dosage of intervention delivered in terms of the amount, frequency, duration,
and breadth would be adequate to assess physical activity levels, physical activity
self-efficacy, cancer-related fatigue, depression, muscle strength, and quality of life, a
research committee is crucial to assess the dosage of the intervention and to train the
volunteer nursing students as coaches for the intervention. In particular, the safety and
appropriateness of the intervention content were reviewed carefully by the committee before
commencement. The members in the committee consist of an associate professor, an assistant
professor and a research student from a local university who are equipped with extensive
experience in conducting different research and particularly, psychosocial interventions for
children with cancer. The committee also includes a professor in paediatric oncology and a
specialist nurse with substantial experience in delivering care to children undergoing cancer
treatment, and an assistant professor who is an expert specialising in sports and recreation
management.
Data Collection Methods
Approval for the study was obtained from the hospital ethics committees. To identify
potential subjects, the research student approach to eligible children and their parents
after screening the medical records in a paediatric oncology ward of a public acute care
hospital in Hong Kong. After explaining the study details, including its purpose, procedures
and potential harms and benefits, parents allowing their children to take part are required
to sign a consent form. In addition, the children who are going to participate are invited to
write down their names on a specially designed child assent form and told that their
participation is voluntary.
Data collection for the outcome variables is conducted at the time of the subject recruitment
(T1), and six (T2), and nine (T3) months after the start of the intervention, except that
physical activity levels of childhood cancer patients are collected at the time of the
subject recruitment (T1), and nine (T2) months after the start of the intervention. Before
randomisation, participants are required to complete the hand grip strength test with the
hand-held dynamometers (HHD) and fill in a set of questionnaires including CUHK-PARCY, the
Chinese versions of PA-SE, fatigue scale, CES-DC, and PedsQL cancer module. Semi-structured
interviews will also be carried out.
Analysis
The Statistical Package for Social Sciences (SPSS) software, version 21.0 for Windows will be
used to analyze quantitative data. Intention-to-treat analysis will be used and missing data
will be substituted by the last-observation-carried-forward procedure. The comparability of
the experimental and control groups will be assessed by using inferential statistics
(independent t-test and chi-squared test). Descriptive statistics will be used to calculate
the mean scores and standard deviation of different scales. Mixed between-within subjects
ANOVA (split-plot ANOVA) and post-hoc analysis using the Tukey procedure will be used to
determine whether the integrated experiential training program with coaching by nursing
students was effective in reducing fatigue, increasing childhood cancer patients' levels of
physical activity, self-efficacy and muscle strength, decreasing depressive symptoms and
enhancing their quality of life. Descriptive phenomenology will be employed during the
process of qualitative data analysis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03826043 -
THrombo-Embolic Event in Onco-hematology
|
N/A | |
Terminated |
NCT03166631 -
A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread
|
Phase 1 | |
Completed |
NCT01938846 -
BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06058312 -
Individual Food Preferences for the Mediterranean Diet in Cancer Patients
|
N/A | |
Completed |
NCT03308942 -
Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants
|
Phase 2 | |
Recruiting |
NCT06018311 -
Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads
|
N/A | |
Withdrawn |
NCT05431439 -
Omics of Cancer: OncoGenomics
|
||
Completed |
NCT01343043 -
A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma
|
Phase 1 | |
Completed |
NCT01938638 -
Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer
|
Phase 1 | |
Recruiting |
NCT05514444 -
Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001)
|
Phase 1 | |
Recruiting |
NCT02292641 -
Beyond TME Origins
|
N/A | |
Terminated |
NCT00954512 -
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
|
Phase 1/Phase 2 | |
Recruiting |
NCT04958239 -
A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors)
|
Phase 1 | |
Recruiting |
NCT04627376 -
Multimodal Program for Cancer Related Cachexia Prevention
|
N/A | |
Completed |
NCT01222728 -
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
|
||
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Active, not recruiting |
NCT05636696 -
COMPANION: A Couple Intervention Targeting Cancer-related Fatigue
|
N/A | |
Not yet recruiting |
NCT06035549 -
Resilience in East Asian Immigrants for Advance Care Planning Discussions
|
N/A | |
Recruiting |
NCT06004466 -
Noninvasive Internal Jugular Venous Oximetry
|
||
Completed |
NCT02909348 -
Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab
|